Physician-led peptide care · US sourced & US manufactured

Press · 2026

The peptide story, reported

Through summer 2026, national newsrooms turned to Mino's physicians to explain what peptides are, how they are sourced and where the line sits between medicine and the gray market. Every placement is listed below with its date and, where one exists, a link.

Audience reached
88M
Placements
64
Linked stories
53

As seen in The Wall Street Journal · Daily Mail · Business of Fashion · NewBeauty · People en Español · SheKnows · Beauty Independent · MedEsthetics · The Purist · ABC 7 Chicago · FOX 5 New York · WGN Chicago · PIX 11 New York

Press inquiries

Where to reach us, market by market

One address for every request — interviews, samples, imagery, fact checks and deadline comment on peptide safety, GLP therapy and US manufacturing. news@kelzmedia.com

Los Angeles

Mino NAD+ was named Best Peptide in Los Angeles Magazine's Best of L.A. Beauty 2026. West Coast interviews, product samples and studio imagery are arranged out of Los Angeles.

New York

Segments on FOX 5 New York and PIX 11, plus print desks at NewBeauty and The Purist. Dr. Amy B. Lewis takes New York broadcast and print bookings in person.

Chicago

Morning-show coverage on ABC 7 Chicago and WGN. Midwest requests for peptide safety, GLP therapy and sourcing commentary route through the same press address.

Tampa Bay & Miami

Florida lifestyle and syndicated segments on the peptide market, telehealth prescribing and what US manufacturing means for patients.

For editors

Mino in four lines

What Mino is

A physician-led peptide program. Every order is reviewed by a licensed prescriber and filled by a US pharmacy partner; nothing ships without a prescription behind it.

Where it is made

US sourced and US manufactured. Every batch is third-party tested for identity, purity and potency before it reaches a member.

How members buy

Mino Passport, a membership at $149, $299 or $399 a month that includes physician visits and lowers the price of every fill.

Recognition

Mino NAD+ was named Best Peptide in Los Angeles Magazine's Best of L.A. Beauty 2026 and entered the People en Español Star Product Hall of Fame.

Online

Digital coverage

National and trade newsrooms, with unique monthly visitors as reported by each title.

22 placements

Broadcast

Television & syndication

Morning shows and lifestyle segments across Chicago, New York and Tampa Bay.

15 placements

Print

Print editions

Newsstand issues carrying Mino's physicians on the record.

1 placement

  • The Purist

    Ask the Dr.

    150K readers

    July 1, 2026

Questions

What reporters ask first

Has Mino been covered by national press?

Yes. The Wall Street Journal, the Daily Mail, Business of Fashion, NewBeauty, SheKnows and People en Español have all covered Mino or the peptide market with Mino's clinicians on the record, alongside broadcast segments on ABC, FOX and WGN.

Who speaks for Mino?

Mino's physician team, led by Dr. Amy B. Lewis, speaks on peptide safety, GLP therapy, sourcing and what regulation means for patients. Requests go to news@kelzmedia.com.

What has Mino won?

Best Peptide in Best of L.A. Beauty 2026 from Los Angeles Magazine, for Mino NAD+, and a place in the People en Español Star Product Hall of Fame 2026.

Are Mino's peptides made in the United States?

Yes. Every peptide Mino dispenses is US sourced, US manufactured and batch tested, and is dispensed only on a prescription written by a licensed physician.

The program behind the coverage